Kaiseraugst, Switzerland

Gilberto Litta

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dsm IP Assets B.v.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilberto Litta: Innovator in Gut Health Formulations

Introduction

Gilberto Litta is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of gut health through his innovative formulations. His work focuses on delivering active agents to the colon, which can provide various benefits to intestinal health.

Latest Patents

Gilberto Litta holds a patent for "Formulations for improving gut health." This patent outlines the delivery of active ingredients such as riboflavin, vitamins A, C, D, E, K, folic acid, β-carotene, and omega-3 fatty acids, among others. The benefits of these formulations include increased concentrations of short-chain fatty acids in the intestine, enhanced microbiome diversity, and improved barrier function of the intestine. Additionally, his work aims to stimulate intestinal immune responses and reduce gas production in the gut.

Career Highlights

Litta is associated with Dsm IP Assets B.V., where he continues to develop and refine his innovative formulations. His dedication to improving gut health has positioned him as a key figure in this area of research.

Collaborations

Some of his notable coworkers include Maaike Johanna Bruins and Sophie Fehlbaum. Their collaborative efforts contribute to the advancement of gut health research and the development of effective formulations.

Conclusion

Gilberto Litta's work in gut health formulations showcases his commitment to enhancing intestinal well-being through innovative solutions. His contributions are paving the way for improved health outcomes in individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…